Skip to main content
Clinical Trials/ISRCTN16878075
ISRCTN16878075
Active, not recruiting
未知

Development and implementation of a pilot programme for lung cancer screening in Belarus

.N. Alexandrov National Cancer Centre0 sites3,000 target enrollmentSeptember 4, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
.N. Alexandrov National Cancer Centre
Enrollment
3000
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2020
End Date
December 2, 2024
Last Updated
5 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
.N. Alexandrov National Cancer Centre

Eligibility Criteria

Inclusion Criteria

  • 1\. Availability of written informed consent
  • 2\. Age from 50 through 70 years
  • 3\. Risk\-based approach a 5\-year lung cancer risk of at least 1\.51% (using the Lung Cancer Risk Assessment Tool)
  • 4\. No advanced chronic lung diseases
  • 5\. No advanced occupational hazard conditions
  • 6\. A clinical\-functional status allowing the possibility to administer surgical treatment

Exclusion Criteria

  • 1\. Second primaries of synchronous and metachronous cancer of both lungs or a combination of lung cancer with cancer of other organs excluding uterine cervix cancer, non\-melanoma skin cancer, and lower lip cancer radically treated at least 3 years ago
  • 2\. Previous special treatment for lung cancer
  • 3\. Acute tuberculosis
  • 4\. Myocardial infarction, stroke in the case history in the course the past 6 months before enrolling in the study
  • Criteria for excluding from the study, based on examination findings:
  • 1\. Congestive heart failure, class III or IV according to NYHA (New York Heart Association) classification, unrelated to the neoplastic process
  • 2\. Uncontrolled severe hypertension or hypertension with systolic pressure \>180 mm Hg and/or diastolic pressure \>110 mm Hg, or orthostatic hypotension
  • 3\. A positive test for human immunodeficiency virus (HIV), B or C hepatitis, or lues
  • 4\. Mental diseases
  • 5\. Chronic alcohol addiction

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Development and preliminary trial of the program for improving work performancenone
JPRN-UMIN000022578ational Institute of Occupational Safety and Health, Japan15
Completed
Not Applicable
Pilot study for the evaluation, development and implementation of a breath test to diagnose oral candidiasisB37.0Candidal stomatitis
DRKS00009391Charité Campus Charité Mitte20
Completed
Not Applicable
Pilot study for the evaluation, development and implementation of a breath test for the early detection of squamous cell carcinomas in the head and neck area (SCCHN).C01C02C04C05C06C09C10Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthMalignant neoplasm of tonsilMalignant neoplasm of oropharynx
DRKS00009539Charité Campus Charité Mitte11
Completed
Not Applicable
Project for the development, piloting and evaluation of an app-based psychosocial prevention measure - First part of the studyAs part of the prevention measure, the strengthening of mental health is focused.
DRKS00030818Technische Universtität München25
Recruiting
Not Applicable
Project for the development, piloting and evaluation of an app-based psychosocial prevention measure - Second part of the studyIndividuals with early signs of a mental health-related participation disorder. The intervention is secondary prevention.
DRKS00033080Technische Universtität München920